1. Home
  2. CXDO vs MOLN Comparison

CXDO vs MOLN Comparison

Compare CXDO & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CXDO

Crexendo Inc.

HOLD

Current Price

$6.84

Market Cap

185.3M

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

N/A

Current Price

$4.33

Market Cap

157.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CXDO
MOLN
Founded
1995
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
185.3M
157.8M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
CXDO
MOLN
Price
$6.84
$4.33
Analyst Decision
Strong Buy
Hold
Analyst Count
4
1
Target Price
$9.13
$3.75
AVG Volume (30 Days)
212.3K
5.2K
Earning Date
11-04-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
201.70
N/A
EPS
0.14
N/A
Revenue
$66,346,000.00
N/A
Revenue This Year
$14.07
N/A
Revenue Next Year
$11.52
$1,000.00
P/E Ratio
$49.15
N/A
Revenue Growth
12.91
N/A
52 Week Low
$3.75
$3.36
52 Week High
$7.65
$5.91

Technical Indicators

Market Signals
Indicator
CXDO
MOLN
Relative Strength Index (RSI) 55.03 53.51
Support Level $6.77 $4.13
Resistance Level $7.05 $4.57
Average True Range (ATR) 0.30 0.14
MACD 0.03 -0.00
Stochastic Oscillator 69.51 54.03

Price Performance

Historical Comparison
CXDO
MOLN

About CXDO Crexendo Inc.

Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: